<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01768741</url>
  </required_header>
  <id_info>
    <org_study_id>SRRSH20121225-2</org_study_id>
    <nct_id>NCT01768741</nct_id>
  </id_info>
  <brief_title>Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma</brief_title>
  <official_title>A Randomized Controlled Trial of Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sir Run Run Shaw Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the clinical value of laparoscopic liver
      resection in the treatment of hepatocellular carcinoma by assessing its Surgical and
      oncologic outcomes comparing with open liver resection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total survival time and disease free survival time</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical margins</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to functional recovery</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity and mortality</measure>
    <time_frame>up to 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative parameters including operation time,pneumoperitoneum time, liver resection time, estimated blood loss,transfusion, as well as number,size and location of the tumor</measure>
    <time_frame>participants will be followed for the duration of operation, an expected average of 90 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regulatory T cells and associated cytokines in peripheral blood</measure>
    <time_frame>up to 5 years</time_frame>
    <description>Regulatory T cells and associated cytokines in peripheral blood will be tested 1day before operation,5 days, 3,6 months and 1,3,5 years after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regulatory T cells and associated cytokines in liver cancer、para-carcinoma and healthy liver tissue</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospital costs</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 9 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>Laparoscopic liver resection group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Open liver resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic liver resection</intervention_name>
    <description>participants will be performed with laparoscopic hepatectomy using laparoscopic instruments</description>
    <arm_group_label>Laparoscopic liver resection group</arm_group_label>
    <other_name>Laparoscopic hepatectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open liver resection</intervention_name>
    <description>participants will be performed with open hepatectomy using laparotomic instruments</description>
    <arm_group_label>Open liver resection</arm_group_label>
    <other_name>Open hepatectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver solid tumor, with clinical diagnosis of hepatocellular carcinoma

          -  Located at segment Ⅱ、Ⅲ、Ⅳb、Ⅴ or Ⅵ

          -  The tumor location and size do not affect the dissection of hepatic hilar region

          -  Tumor size less than 10cm

          -  Without portal vein tumor thrombus

          -  Without intrahepatic or distant metastasis

          -  Willingness to participate in the study

          -  Able to understand the nature of the study and what will be required of them

          -  Body mass index of between 18 and 35

          -  Child-Pugh classification of A to B

          -  American Society of Anesthesiologists (ASA) grading of I to III

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Unwillingness to participate

          -  Inability to give written informed consent

          -  Child-Pugh classification of C

          -  ASA grading of IV to V

          -  Tumor invasion of the inferior vena cava or confluence part of hepatic vein

          -  Decompensated liver cirrhosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiujun Cai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sir Run Run Shaw Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiujun Cai, MD</last_name>
    <phone>0086-0571-86006605</phone>
    <email>caixiujunzju@yahoo.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiujun Cai, MD</last_name>
      <phone>0086-0571-86006605</phone>
      <email>caixiujunzju@yahoo.com.cn</email>
    </contact>
    <contact_backup>
      <last_name>Renan Jin, MS</last_name>
      <phone>0086-0571-86006276</phone>
      <email>jason198508@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2013</study_first_submitted>
  <study_first_submitted_qc>January 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2013</study_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sir Run Run Shaw Hospital</investigator_affiliation>
    <investigator_full_name>Xiujun Cai</investigator_full_name>
    <investigator_title>Executive Vice-President</investigator_title>
  </responsible_party>
  <keyword>hepatocellular carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

